This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
New Data, Case Studies & Partners
September 10th-11th, 2025Boston Exhibition & Convention Center, USA
Menu

Gilles Divita
CSO at Aanastra/ CEO at Divincell SAS
Speaker

Profile

Gilles DIVITA PhD is founder CEO of DIVINCELL and CSO at AANASTRA LLC, California (USA) a BioPharmaceutical NanoMedicine Start-up pioneering a novel RNA therapeutic drug delivery for the treatment of cancer and genetic diseases . His has over 25 years of experience in drug delivery systems, peptide-drugs and oligonucleotide therapeutics. Dr Divita is the pioneer of the “non covalent cell penetrating peptide-based strategy” for therapeutic delivery and inventor of the peptide-based platform for RNA therapeutic strategy. His is author of over 200 articles in peer reviewed scientific journals and of 30 granted patents.

Agenda Sessions

  • Peptide-Based Nanoparticle-Platform for Targeted Delivery of Functional mRNAs Targeting Genetic Disorders in Cancer

    , 9:30am
    View Session

At this event

Prev
Next
Ramana Doppalapudi
VP, Chemistry
Avidity Biosciences

See Gilles at RNA Leaders USA